Evotec SE EVO
NASDAQ EVO
$1.81 -0.01 (-0.55%)
At close: Sep 9, 2026 · 4:00 PM EDT

Evotec SE (EVO) Total Debt Growth (1y) (2010 - 2026)

Analysis

Evotec SE (EVO) Total Debt Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (1y) (Qtr)
1 Iqvia Holdings 42.77 Bn 40.69 Bn 1.44 Bn 3.29%
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn -
3 Charles River Laboratories International 13.37 Bn 13.18 Bn 452.07 Mn 12.33%
4 Icon 12.49 Bn 11.56 Bn 479.29 Mn -0.69%
5 Fortrea Holdings 1.58 Bn 1.42 Bn 139.20 Mn -10.33%
6 Evotec SE 642.83 Mn 216.96 Mn - 5.75%
7 Ginkgo Bioworks Holdings 422.55 Mn 338.02 Mn 18.44 Mn -
8 Champions Oncology 69.16 Mn 69.16 Mn 7.03 Mn -
9 MindWalk Holdings 59.83 Mn 51.55 Mn 1.82 Mn -
10 VivoSim Labs 1.45 Mn 1.45 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.75%
Mar 31, 2026 -9.92%
Dec 31, 2025 10.21%
Sep 30, 2025 9.75%
Dec 31, 2024 -29.65%
Dec 31, 2023 28.54%
Jun 30, 2023 265.45%
Dec 31, 2022 26.41%
Sep 30, 2022 -2.92%
Dec 31, 2021 0.40%
Jun 30, 2010 -52.50%
Mar 31, 2010 -90.26%